ストックスクリーナーアプリを入手
16.63
0.72%
-0.12
前日終値:
$16.75
開ける：
$16.57
24時間の取引高:
740.01K
Relative Volume:
1.07
時価総額：
$2.19B
収益：
-
当期純損益:
$-151.09M
株価収益率:
-10.66
EPS:
-1.56
ネットキャッシュフロー:
$-160.51M
1週間 パフォーマンス:
-2.58%
1か月 パフォーマンス:
+1.03%
6か月 パフォーマンス:
+36.20%
1年 パフォーマンス:
+59.90%
1日の値動き範囲:
$16.14
$17.07
1週間の範囲:
$15.49
$17.47
52週間の値動き範囲:
$7.75
$19.09
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
名前
Centessa Pharmaceuticals Plc Adr
セクター
電話
44 7391 789784
住所
3RD FLOOR, ALTRINCHAM, CHESHIRE
CNTA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
16.63 | 2.19B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-09-20 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | 開始されました | B. Riley Securities | Buy |
| 2024-07-18 | 開始されました | Oppenheimer | Outperform |
| 2023-11-15 | アップグレード | Jefferies | Hold → Buy |
| 2023-10-26 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | 開始されました | Evercore ISI | Outperform |
| 2023-06-12 | 開始されました | Guggenheim | Buy |
| 2023-03-17 | 開始されました | SVB Securities | Outperform |
| 2022-08-12 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-06-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-02-11 | 開始されました | Goldman | Neutral |
すべてを表示
Centessa Pharmaceuticals Plc Adr (CNTA) 最新ニュース
Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.
Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India
Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News
Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News
Centessa Pharmaceuticals plc ADR (CNTA) Volatility Hits 6.67%: What Good Investors Need To Be Aware Of - Stocks Register
RLI Corp’s (RLI) Stock: A Week-by-Week Analysis - The News Heater
Centessa Pharmaceuticals plc ADR (CNTA) Shares Up Despite Recent Market Volatility - The News Heater
Aon plc (AON) Stock: Evaluating the Market Performance - The News Heater
Qudian Inc ADR (QD) Stock: A Look at the Analyst Recommendations - The News Heater
Examining the Volatility of Costamare Inc’s (CMRE) Stock - The News Heater
Centessa Pharmaceuticals officer Tia Bush sells $185,406 in shares - Investing.com
Financial Fitness Check: Examining Magna International Inc (MGA)’s Key Ratios - The Dwinnex
Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex
Financial Health Report: EyePoint Pharmaceuticals Inc (EYPT)’s Ratios Tell a Tale - The Dwinnex
A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News
Centessa Pharmaceuticals chief business officer sells shares worth $193,429 - Investing.com India
Centessa Pharmaceuticals general counsel Hussain Iqbal sells $91,740 in shares - Investing.com
Centessa Pharmaceuticals appoints new Chief Medical Officer - Investing.com
Centessa Pharmaceuticals' chief business officer sells shares worth $170,399 - Investing.com
Centessa Pharmaceuticals CEO sells $959,057 in shares - Investing.com India
Centessa Pharmaceuticals general counsel sells shares for $1.27 million By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals general counsel sells shares for $1.27 million - Investing.com
Stock Market Recap: Tencent Music Entertainment Group ADR (TME) Concludes at 11.30, a -5.68 Surge/Decline - The Dwinnex
Banzai International Inc (NASDAQ: BNZI): Getting A Free Pass? - Stocks Register
Metrics That Matter About Credo Technology Group Holding Ltd (NASDAQ: CRDO) - Stocks Register
Centessa Pharmaceuticals stock hits 52-week high at $18.77 By Investing.com - Investing.com UK
Centessa Pharmaceuticals CEO Saha Saurabh sells $5,450 in shares - Investing.com India
Centessa Pharmaceuticals' chief business officer sells $176,601 in shares - Investing.com
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million - Investing.com India
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million By Investing.com - Investing.com South Africa
Deutsche Bank initates Fidelity National Financial Inc (FNF) stock to a Hold - Knox Daily
Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India
Endava PLC Sponsored ADR (DAVA) Beats Q1 Earnings Estimates - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance
Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com
Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - Yahoo Finance
Centessa Pharmaceuticals plcADR (CNTA) Price Target Increased by 14.58% to 11.22 - MSN
Centessa Pharmaceuticals CEO sells shares worth $863,727 - Investing.com
Are Finance Stocks Lagging Balfour Beatty PLC Sponsored ADR (BLFBY) This Year? - Yahoo Finance
Centessa Pharmaceuticals plc ADR (CNTA) expanding its growth trajectory ahead - SETE News
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Analysts review Bilibili Inc ADR’s rating - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) shows promising results - US Post News
Ratios Uncovered: Breaking Down Centessa Pharmaceuticals plc ADR (CNTA)’s Trailing Twelve Months Metrics - The Dwinnex
Centessa Pharmaceuticals executive sells over $260k in company stock - Investing.com India
Centessa Pharmaceuticals executive sells over $260k in company stock By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals plc ADR [CNTA] Shares Rise 2.15 % on Thursday - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) is looking forward to a strong quarter - SETE News
Centessa Pharmaceuticals Plc Adr (CNTA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):